Harrow Stock

Harrow Diluted EPS

The Diluted Earnings per Share of Harrow (HROW) as of Aug 19, 2026 is -0.14 USD. In the previous year, Diluted Earnings per Share was -0.49 USD — a change of -71.36% (higher).

Diluted EPS

-0.14USD

YoY

-71.36%

Last updated:

Diluted Earnings per Share of Harrow is 2026 -0.14 USD. Diluted Earnings per Share of Harrow was 2025 -0.49 USD. It decreases by -71.36% higher compared to the previous year.
Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

Diluted Earnings per Share of Harrow is -0.14 USD in 2026.

Diluted Earnings per Share of Harrow changed from -0.49 USD to -0.14 USD, representing a -71.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Harrow since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

Income Statement — Harrow

All Key Metrics — Harrow